Contact

If you’d like to contact us, please use the email form below or our direct email address: info@dr-erkens-consulting.de. You can of course also reach us by phone: Tel: +49 6154 6967-944 oder mobile +49 179 2 41 10 29

When filling out the email form, please note that we need at least your name and email address to send you a reply. If you’d like us to call you back, please enter a telephone number where we can reach you. If you’d like us to send you information, please enter your address.

Your message to us:

Prefix

Title

other Title

First Name

Last Name

Street / Number

ZIP / Postal Code

City

Phone

Mobile

Callback Callback Phone Mobile

e-mail

Message

Data Privacy Policy Data Privacy Policy I have taken note of the Data Privacy Policy. I consent to my details and data being collected and stored electronically for the purpose of answering my inquiry. Please note: you can at any time withdraw your consent for the future by emailing info@dr-erkens-consulting.de. [To the Data Privacy Policy...]

Adress

Dr. Erkens Consulting Group
Industriestraße 13
64380 Roßdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de

Social

News

Dr. Erkens Consulting Group

Website-Relaunch of Dr. Erkens Consulting Group
Source: Dr. Erkens Consulting Group 09/2020
Integrated Pharma-News at Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020

Pharma Letter

Catalent to support Galapagos’ decentralized cell therapy approach
Source: Pharma Letter Published on 2025-01-21
Dermal pharmacology: challenges facing generic topical and transdermal drug development
Source: Pharma Letter Published on 2025-01-21
CAR-T patent filings peaking, law firm finds
Source: Pharma Letter Published on 2025-01-21
Arvinas looks for new chief commercial officer
Source: Pharma Letter Published on 2025-01-21
J&J’s Spravato first approval as monotherapy for treatment-resistant depression
Source: Pharma Letter Published on 2025-01-21

Pharma Relations

#Wachbeben in Deutschland
Source: Pharma Relations Published on 2024-02-07
"isla" gibt sozialen Projekten eine Stimme
Source: Pharma Relations Published on 2024-02-06
TK bietet psychoonkologische Unterstützung durch Living Well Plus-App
Source: Pharma Relations Published on 2024-02-06
DP-Medconnect mit neuer Führung
Source: Pharma Relations Published on 2024-02-06
Wort & Bild übernimmt das Fachmagazin "PTA Woman"
Source: Pharma Relations Published on 2024-02-06

Pharma Times

AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025
Source: Pharma Times Published on 2025-01-21
EC approves lazertinib in combination with amivantamab for NSCLC patients
Source: Pharma Times Published on 2025-01-21
UK sees 70% increase in phase I advanced therapy clinical trials in 2024
Source: Pharma Times Published on 2025-01-20
Datapharm expands into US market through partnership with phactMI
Source: Pharma Times Published on 2025-01-20
Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials
Source: Pharma Times Published on 2025-01-16

PZ online

Coesfeld: NRW-Ministerpräsident Wüst besucht Apotheke
Source: PZ online Published on 2025-01-21
Fieber bei Kindern: Nicht nur die Temperatur zählt
Source: PZ online Published on 2025-01-21
TI-Messenger : CompuGroup Medical erhält Zulassung
Source: PZ online Published on 2025-01-21
Bankenabend: Krieg, Frieden und Zeitenwende: Worauf sich Europa einstellen muss
Source: PZ online Published on 2025-01-21
Verschreibungspflicht: Sildenafil bleibt rezeptpflichtig, Naloxon-Nasenspray nicht
Source: PZ online Published on 2025-01-21

Our Place on Earth

Kartenbild: OpenStreetMap, ODbL 1.0